FDA approves Kcentra for the urgent reversal of anticoagulation in adults with major bleeding

FDA approves Kcentra for the urgent reversal of anticoagulation in adults with major bleeding

04/29/2013 05:56 PM EDT

The U.S. Food and Drug Administration today approved Kcentra (Prothrombin Complex Concentrate, Human) for the urgent reversal of vitamin K antagonist (VKA) anticoagulation in adults with acute major bleeding. Plasma is the only other product approved for this use in the United States.